Heart Sphingolipids in Health and Disease
- 1 January 2011
- book chapter
- Published by Springer Nature
- Vol. 721, 41-56
Abstract
In recent years, the role of sphingolipids in physiology and pathophysiology of the heart attracted much attention. Ceramide was found to be involved in the pathogenesis of cardiac dysfunction in animal models of ischemia/reperfusion injury, Type 2 diabetes and lipotoxic cardiomyopathy. On the other hand, another member of this lipid family, namely sphingosine-1-phosphate, has been shown to possess potent cardioprotective properties. This chapter provides a review of the role of ceramide and other bioactive sphingolipids in physiology and pathophysiology of the heart. We describe the role of PPARs and exercise in regulation of myocardial sphingolipid metabolism. We also summarize the present state of knowledge on the involvement of ceramide and sphingosine-1-phosphate in the development and prevention of ischemia/reperfusion injury of the heart. In the last section of this chapter we discuss the evidence for a role of ceramide in myocardial lipotoxicity.Keywords
This publication has 65 references indexed in Scilit:
- Myocardium of type 2 diabetic and obese patients is characterized by alterations in sphingolipid metabolic enzymes but not by accumulation of ceramideJournal of Lipid Research, 2010
- DGAT1 Expression Increases Heart Triglyceride Content but Ameliorates LipotoxicityJournal of Biological Chemistry, 2009
- Sphingosine 1-phosphate is an important endogenous cardioprotectant released by ischemic pre- and postconditioningAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- Targeting sphingosine-1-phosphate signalling for cardioprotectionCurrent Opinion in Pharmacology, 2009
- Sphingosine Kinase and Sphingosine 1-Phosphate in CardioprotectionJournal of Cardiovascular Pharmacology, 2009
- Sphingosine-1-phosphate receptor signalling in the heartCardiovascular Research, 2008
- Ceramide is a cardiotoxin in lipotoxic cardiomyopathyJournal of Lipid Research, 2008
- Adaptation and Maladaptation of the Heart in ObesityHypertension, 2008
- Cardiomyocyte expression of PPARγ leads to cardiac dysfunction in miceJournal of Clinical Investigation, 2007
- Adaptation and Maladaptation of the Heart in Diabetes: Part IICirculation, 2002